Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Safe Supply Streaming Portfolio Company Safety Strips, Provides Corporate Update (click to learn more)
Saturn Oil & Gas Inc. Announces $525 Million Accretive Core-Area Saskatchewan Asset Acquisition (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sanofi Ord Shs
SNYNF
Healthcare
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood...
Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCPK:SNYNF)
New Post
View:
Posts & Comments
Threaded Posts
(92)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Apr 25, 2024 3:45pm
Drugmaker Sanofi's Strong Dupixent And Beyfortus Vaccine Sal
Breaking News: $SNY Drugmaker Sanofi's Strong Dupixent And Beyfortus Vaccine Sales Propel Q1 Earnings | BenzingaThursday,@Sanofi SA@(NASDAQ:SNY)@reported@first-quarter operating income of 2.8
...more
(10)
•••
Blocky
X
View Profile
View Bullboard History
Post by
Blocky
on Jan 08, 2021 10:27am
Sanofi and Covid19? WPD Pharma...
Sanofi could easily buy WPD Pharma, who develop a Covid19-drug called WP1122. Did you read this? https://www.globenewswire.com/news-release/2020/08/17/2079327/0/en/WPD-Pharmaceuticals-Enters-into
...more
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support
posted May 08, 2024 9:00am by
Numinus Wellness Inc
-
|
"We are excited to enter this next stage of our development, which sharpens our focus on expanding access to psychedelic-assisted therapies and accelerates our path to profitability. We aim to empower a broader community of drug developers and healthcare providers by optimizing our therapy, research, and training expertise. This strategic focus is about bringing transformative treatments ...read more
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Jan 02, 2021 6:42pm
Happy new year Do your Own DD
https://www.globenewswire.com/news-release/2020/12/31/2151927/0/en/MedMira-Announces-Product-Update.html
(495)
•••
Mil_Man54
X
View Profile
View Bullboard History
Post by
Mil_Man54
on Dec 26, 2020 8:30am
Bonvoyage12.....Lying Pumper
Ignore this clown as he posts lies trying to mislead investors about the actual state of the company...he also posts this same BS on multiple boards
(9)
•••
schoolofrock
X
View Profile
View Bullboard History
Post by
schoolofrock
on Oct 07, 2020 7:52am
Vaccine Stocks - Can the President Overrule the FDA?
An approval cycle that typically takes years is being expedited. In the case of the 2020 pandemic, the FDA has shortened standard testing periods and is providing timely advice and closer than
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Meet one of the Strongest Contenders to Lead Canada’s Cannabis Market
Multiple High-Grade Gold Hits at the Tonopah Gold Project Including 90 Meters at 2.0 gpt Gold
A Leading Provider in Virtual Healthcare Adds 4th Provincial Health Authority Contract
NOI Filed for Drill Program at Lithium/Uranium Project in Nevada
Silvercorp to Acquire Adventus for Implied Consideration of C$0.50 per Share